Tag: IL-36 pathway

Boehringer Ingelheim and LEO Pharma Enter Partnership to Commercialize and Further Develop SPEVIGOยฎ

Boehringer Ingelheim and LEO Pharma today announced an exclusive global license and…

ME Desk